Gallagher WM - Search Results

1

Commercialized biomarkers: new horizons in prostate cancer diagnostics.

Murphy L, Prencipe M, Gallagher WM, Watson RW. Murphy L, et al. Among authors: gallagher wm. Expert Rev Mol Diagn. 2015 Apr;15(4):491-503. doi: 10.1586/14737159.2015.1011622. Epub 2015 Feb 24. Expert Rev Mol Diagn. 2015. PMID: 25711191 Review.

2

Automated image analysis in histopathology: a valuable tool in medical diagnostics.

Mulrane L, Rexhepaj E, Penney S, Callanan JJ, Gallagher WM. Mulrane L, et al. Among authors: gallagher wm. Expert Rev Mol Diagn. 2008 Nov;8(6):707-25. doi: 10.1586/14737159.8.6.707. Expert Rev Mol Diagn. 2008. PMID: 18999923 Review.

3

Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM. Brennan DJ, et al. Among authors: gallagher wm. Nat Rev Cancer. 2010 Sep;10(9):605-17. doi: 10.1038/nrc2902. Epub 2010 Aug 19. Nat Rev Cancer. 2010. PMID: 20720569 Review.

4

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.

O'Neill AJ, Prencipe M, Dowling C, Fan Y, Mulrane L, Gallagher WM, O'Connor D, O'Connor R, Devery A, Corcoran C, Rani S, O'Driscoll L, Fitzpatrick JM, Watson RW. O'Neill AJ, et al. Among authors: gallagher wm. Mol Cancer. 2011 Oct 7;10:126. doi: 10.1186/1476-4598-10-126. Mol Cancer. 2011. PMID: 21982118 Free PMC article.

5

Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.

Joyce CW, Murphy IG, Rafferty M, Ryan D, McDermott EW, Gallagher WM. Joyce CW, et al. Among authors: gallagher wm. Expert Rev Proteomics. 2012 Aug;9(4):415-23. doi: 10.1586/epr.12.5. Expert Rev Proteomics. 2012. PMID: 22967078 Review.

6

Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?

Prencipe M, Madden SF, O'Neill A, O'Hurley G, Culhane A, O'Connor D, Klocker H, Kay EW, Gallagher WM, Watson WR. Prencipe M, et al. Among authors: gallagher wm. Prostate. 2013 May;73(7):743-53. doi: 10.1002/pros.22618. Epub 2013 Jan 28. Prostate. 2013. PMID: 23359479

7

Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arena.

Currid CA, Gallagher WM. Currid CA, et al. Among authors: gallagher wm. Expert Opin Med Diagn. 2008 Sep;2(9):1091-4. doi: 10.1517/17530059.2.9.1091. Expert Opin Med Diagn. 2008. PMID: 23495928

8

The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.

O'Hurley G, Prencipe M, Lundon D, O'Neill A, Boyce S, O'Grady A, Gallagher WM, Morrissey C, Kay EW, Watson RW. O'Hurley G, et al. Among authors: gallagher wm. Prostate. 2014 Feb;74(3):306-13. doi: 10.1002/pros.22752. Prostate. 2014. PMID: 24249383

9

microRNAs: a new class of breast cancer biomarkers.

Mulrane L, Klinger R, McGee SF, Gallagher WM, O'Connor DP. Mulrane L, et al. Among authors: gallagher wm. Expert Rev Mol Diagn. 2014 Apr;14(3):347-63. doi: 10.1586/14737159.2014.901153. Expert Rev Mol Diagn. 2014. PMID: 24649821 Review.

10

Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers.

O'Hurley G, Sjöstedt E, Rahman A, Li B, Kampf C, Pontén F, Gallagher WM, Lindskog C. O'Hurley G, et al. Among authors: gallagher wm. Mol Oncol. 2014 Jun;8(4):783-98. doi: 10.1016/j.molonc.2014.03.008. Epub 2014 Mar 21. Mol Oncol. 2014. PMID: 24725481 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page